• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性呼吸衰竭期间下呼吸道无创采样的研究重点:美国胸科学会官方研讨会报告

Research Priorities for Noninvasive Sampling of the Lower Respiratory Tract during Acute Respiratory Failure: An Official American Thoracic Society Workshop Report.

作者信息

Bain William, Sarma Aartik, Morales-Nebreda Luisa, Rizzo Alicia N, Herron Malcolm, Wright Shelton W, Hagan Robert S, Vigeland Christine L, Mwizerwa Erin, Pickens Chiagozie, Toth Susan, Nonoyama Mika, Cao Bin, Luna Carlos M, Rubin Eileen, Torres Antoni, Bos Lieuwe D, McVerry Bryan J, Restrepo Marcos I, Baron Rebecca M, Ware Lorraine B, Kulkarni Hrishikesh S, Calfee Carolyn S, Rogers Angela J, Wunderink Richard G, Varisco Brian M, Dela Cruz Charles S, Kitsios Georgios D, Mock Jason R, Morrell Eric D, McElvaney Noel G, Bastarache Julie A

出版信息

Ann Am Thorac Soc. 2025 Aug;22(8):1101-1114. doi: 10.1513/AnnalsATS.202505-543ST.

DOI:10.1513/AnnalsATS.202505-543ST
PMID:40748053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12329329/
Abstract

Research using lower respiratory tract (LRT) sampling may lead to improved understanding and management of patients with acute respiratory failure (ARF). Research bronchoscopy is a valuable tool for sampling the LRT during ARF. However, bronchoscopy may be limited by challenges with repeated sampling, the inability to sample the most severely ill patients, and increased resource utilization. "Noninvasive" sampling strategies, such as nonbronchoscopic bronchoalveolar lavage, endotracheal aspirate collection, and heat moisture exchange filter fluid collection, may expand the opportunity to collect LRT samples for research. Upper respiratory tract and sputum sampling may enable sampling in nonintubated patients with ARF, for whom there is no direct noninvasive access to the LRT. We convened a workshop with 32 experts from diverse continents, scientific backgrounds, and healthcare professions, all with experience in clinical or research practice during ARF. The Workshop goals were to review existing noninvasive sampling methods, evaluate their respective potential benefits and limitations, and identify future research priorities aimed at improving standardization and integration of these approaches into practice. Findings were generated by review of literature, expert presentations, meeting discussions, and electronic surveys using a modified Delphi approach. Participants agreed that each sampling method provides biologically meaningful data during ARF while also acknowledging that each method has benefits and limitations. Various potential advantages to noninvasive methods include reduced cost, enhanced speed, and ease of adoption compared with standard fiberoptic bronchoscopy. Despite the potential advantages, rigorous head-to-head comparisons between noninvasive methods and/or standard bronchoscopy are limited, which is a priority for future research. Additional research priorities include examination of the feasibility and benefit of serial sampling of the LRT and investigation of how LRT biomarkers are related to lung pathophysiology and patient-centered clinical outcomes during ARF. This Workshop Report provides guidance for investigators to integrate LRT sampling into their research and highlights key priorities, such as rigorous head-to-head comparison of sampling methods for research, to improve the standardization of noninvasive sampling methods and use of LRT sampling in research and clinical practice.

摘要

使用下呼吸道(LRT)采样的研究可能有助于提高对急性呼吸衰竭(ARF)患者的理解和管理水平。研究性支气管镜检查是在ARF期间对LRT进行采样的一种有价值的工具。然而,支气管镜检查可能受到重复采样的挑战、无法对病情最严重的患者进行采样以及资源利用增加的限制。“非侵入性”采样策略,如非支气管镜下支气管肺泡灌洗、气管内吸出物采集和热湿交换过滤器液体采集,可能会扩大为研究采集LRT样本的机会。上呼吸道和痰液采样可以使未插管的ARF患者进行采样,对于这些患者而言,无法直接通过非侵入性方法获取LRT样本。我们召集了一个由来自不同大陆、具有不同科学背景和医疗专业的32位专家组成的研讨会,所有专家都有在ARF期间进行临床或研究实践的经验。研讨会的目标是回顾现有的非侵入性采样方法,评估它们各自的潜在益处和局限性,并确定未来的研究重点,以提高这些方法的标准化程度并将其整合到实践中。通过文献综述、专家报告、会议讨论以及采用改良德尔菲法的电子调查得出了研究结果。参与者一致认为,每种采样方法在ARF期间都能提供具有生物学意义的数据,同时也承认每种方法都有其益处和局限性。与标准纤维支气管镜检查相比,非侵入性方法的各种潜在优势包括成本降低、速度提高和易于采用。尽管有潜在优势,但非侵入性方法与标准支气管镜检查之间严格的直接比较有限,这是未来研究的一个重点。其他研究重点包括检查LRT连续采样的可行性和益处,以及研究在ARF期间LRT生物标志物如何与肺病理生理学和以患者为中心的临床结果相关联。本研讨会报告为研究人员将LRT采样整合到其研究中提供了指导,并突出了关键重点,如对研究采样方法进行严格的直接比较,以提高非侵入性采样方法的标准化程度以及在研究和临床实践中使用LRT采样。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/12329329/e759a2569daa/AnnalsATS.202505-543STf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/12329329/8869e0396232/AnnalsATS.202505-543STf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/12329329/41ecf42d5ab1/AnnalsATS.202505-543STf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/12329329/e759a2569daa/AnnalsATS.202505-543STf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/12329329/8869e0396232/AnnalsATS.202505-543STf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/12329329/41ecf42d5ab1/AnnalsATS.202505-543STf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f769/12329329/e759a2569daa/AnnalsATS.202505-543STf3.jpg

相似文献

1
Research Priorities for Noninvasive Sampling of the Lower Respiratory Tract during Acute Respiratory Failure: An Official American Thoracic Society Workshop Report.急性呼吸衰竭期间下呼吸道无创采样的研究重点:美国胸科学会官方研讨会报告
Ann Am Thorac Soc. 2025 Aug;22(8):1101-1114. doi: 10.1513/AnnalsATS.202505-543ST.
2
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗。
Cochrane Database Syst Rev. 2024 May 3;5(5):CD009530. doi: 10.1002/14651858.CD009530.pub5.
3
Systemic Inflammatory Response Syndrome全身炎症反应综合征
4
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2016 Jan 21(1):CD009530. doi: 10.1002/14651858.CD009530.pub3.
5
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2013 Dec 23(12):CD009530. doi: 10.1002/14651858.CD009530.pub2.
6
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2018 Sep 17;9(9):CD009530. doi: 10.1002/14651858.CD009530.pub4.
7
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.体外二氧化碳清除治疗急性低氧性呼吸衰竭:REST随机对照试验
Health Technol Assess. 2025 Jul;29(33):1-16. doi: 10.3310/GJDM0320.
8
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.

本文引用的文献

1
Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiency.优化支气管肺泡灌洗:来自α-1抗胰蛋白酶缺乏症的经验教训。
Thorax. 2024 Dec 23;80(1):24-31. doi: 10.1136/thorax-2024-221797.
2
The bronchoalveolar lavage dilution conundrum: an updated view on a long-standing problem.支气管肺泡灌洗稀释之谜:一个长期存在问题的最新观点。
Am J Physiol Lung Cell Mol Physiol. 2024 Nov 1;327(5):L807-L813. doi: 10.1152/ajplung.00054.2024. Epub 2024 Oct 8.
3
PD-L1 and PD-1 Are Associated with Clinical Outcomes and Alveolar Immune Cell Activation in Acute Respiratory Distress Syndrome.
PD-L1 和 PD-1 与急性呼吸窘迫综合征的临床结局和肺泡免疫细胞激活相关。
Am J Respir Cell Mol Biol. 2024 Nov;71(5):534-545. doi: 10.1165/rcmb.2024-0201OC.
4
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19.地塞米松对重症 COVID-19 的肺部和全身作用不同。
Nat Commun. 2024 Jun 28;15(1):5483. doi: 10.1038/s41467-024-49756-2.
5
Early Detection of Ventilator-associated Pneumonia From Exhaled Breath in Intensive Care Unit Patients.从 ICU 患者的呼气中早期检测呼吸机相关性肺炎。
Ann Surg. 2024 Sep 1;280(3):394-402. doi: 10.1097/SLA.0000000000006409. Epub 2024 Jun 26.
6
Longitudinal multicompartment characterization of host-microbiota interactions in patients with acute respiratory failure.急性呼吸衰竭患者宿主-微生物群相互作用的纵向多室特征分析。
Nat Commun. 2024 Jun 3;15(1):4708. doi: 10.1038/s41467-024-48819-8.
7
Can linezolid be validly measured in endotracheal aspiration in critically ill patients? A proof-of-concept trial.利奈唑胺能否在重症患者的气管内吸出物中得到有效检测?一项概念验证试验。
Intensive Care Med Exp. 2024 May 8;12(1):47. doi: 10.1186/s40635-024-00630-x.
8
Lung Epithelium Releases Growth Differentiation Factor 15 in Response to Pathogen-mediated Injury.肺上皮细胞在病原体介导的损伤下释放生长分化因子 15。
Am J Respir Cell Mol Biol. 2024 May;70(5):379-391. doi: 10.1165/rcmb.2023-0429OC.
9
Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial.个体化短疗程抗生素治疗与呼吸机相关性肺炎常规长疗程治疗的比较(REGARD-VAP):一项多中心、个体随机、开放标签、非劣效性试验
Lancet Respir Med. 2024 May;12(5):399-408. doi: 10.1016/S2213-2600(23)00418-6. Epub 2024 Jan 22.
10
Microbiome Profiling Demonstrates Concordance of Endotracheal Tube Aspirates With Direct Lower Airway Sampling in Intubated Patients.微生物组分析显示,气管内抽吸物与插管患者直接下呼吸道标本具有一致性。
Chest. 2024 Jun;165(6):1415-1420. doi: 10.1016/j.chest.2024.01.007. Epub 2024 Jan 9.